Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Stephens & Co. Maintains Overweight on Akoya Biosciences, Lowers Price Target to $9

Author: Benzinga Newsdesk | November 13, 2023 10:13am

Stephens & Co. analyst Mason Carrico maintains Akoya Biosciences (NASDAQ:AKYA) with a Overweight and lowers the price target from $14 to $9.

Posted In: AKYA